Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection

Gene Therapy

Volumn 14, Issue 21, 2007, Pages 1549-1554

  Sangiolo, D ^a,b   Lesnikova, M ^a   Nash, R A ^a,c   Jensen, M C ^d   Niktine, A ^a   Kiem, H P ^a,b   Georges, G E ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GANCICLOVIR; INOSINATE DEHYDROGENASE; LENTIVIRUS VECTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMIDINE KINASE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CD34 SELECTION; CELL SELECTION; CONTROLLED STUDY; GENETIC LINKAGE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS EXPRESSION; VIRUS RESISTANCE; VIRUS VIRULENCE;

ANTIVIRAL AGENTS; CELL PROLIFERATION; CLONING, MOLECULAR; DRUG RESISTANCE; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC ENGINEERING; GENETIC VECTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; K562 CELLS; MYCOPHENOLIC ACID; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

SIMPLEXVIRUS;

EID: 35348853841     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303018     Document Type: Article

References (24)

1. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
2. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux J-M et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333-1341.
3. Garin MI, Garrett E, Tiberghien P, Apperley JF, Chalmers D, Melo JV et al. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 2001; 97: 122-129.
4. + stem cells. Mol Ther 2006; 14: 236-244.
5. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action (Review). Immunopharmacology 2000; 47: 85-118.
6. Sintchak MD, Fleming MA, Futer O, Raybuck SA, Chambers SP, Caron PR et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 1996; 85: 921-930.
7. Lightfoot T, Snyder FF. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid. Biochim Biophys Acta 1994; 1217: 156-162.
8. Hodges SD, Fung E, McKay DJ, Renaux BS, Snyder FF. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells. J Biol Chem 1989; 264: 18137-18141.
9. Plautz G, Nabel EG, Nabel GJ. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 1991; 3: 709-715.
10. Martin PJ. Overview of hematopoietic cell transplantation immunology. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation. Blackwell Publishing Ltd: Oxford, UK, 2004 pp 16-30.
11. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994; 83: 1988-1997.
12. Rettig MP, Ritchey JK, Meyerrose TE, Haug JS, DiPersio JF. Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease. Mol Ther 2003; 8: 29-41.
13. Sandrin V, Boson B, Salmon P, Gay W, Negre D, Le Grand R et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002; 100: 823-832.
14. Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 1996; 87: 2579-2587.
15. Davis BM, Roth JC, Liu L, Xu-Welliver M, Pegg AE, Gerson SL. Characterization of the P140 K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: Implications for drug resistance gene therapy. Hum Gene Ther 1999; 10: 2769-2778.
16. Davis BM, Koc ON, Gerson SL. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 2000; 95: 3078-3084.
17. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson LA, Manley SA et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996; 2: 216-223.
18. Morris JC, Conerly M, Thomasson B, Storek J, Riddell SR, Kiem H-P. Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. Blood 2004; 103: 492-499.
19. Georges GE, Storb R, Brunvand MW, Kiem H-P, Moore PF, Malik P et al. Canine T cells transduced with a herpes simplex virus thymidine kinase gene: A model to study effects on engraftment and control of graft-versus-host disease. Transplantation 1998; 66: 540-544.
20. Georges GE, Storb R, Bruno B, Brodie SJ, Thompson JD, Taranova AG et al. Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes. Blood 2001; 98: 3447-3455.
21. Berger C, Flowers ME, Warren EH, Riddell SR. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. Blood 2006; 107: 2294-2302.
22. Giaccone L, McCune JS, Maris MB, Gooley TA, Sandmaier BM, Slattery JT et al. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood 2005; 106: 4381-4388.
23. Horn PA, Morris JC, Bukovsky AA, Andrews RG, Naldini L, Kurre P et al. Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Therapy 2002; 9: 1464-1471.
24. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.